| Recruiting | A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma | Phase 2 | 2025-03-12 |
| Completed | A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects Blood Pressure | Phase 4 | 2022-01-25 |
| Completed | A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity Adolescent Obesity, Obesity in Adolescence, Adolescent Overweight | Phase 4 | 2019-05-02 |
| Completed | A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents Pediatric Obesity, Childhood Obesity | Phase 4 | 2016-03-01 |
| Completed | Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects Obesity | Phase 4 | 2014-08-01 |
| Completed | Safety Study Looking at the Effects of Stendra on Vision Vision | Phase 4 | 2014-01-01 |
| Completed | Study Evaluating the Effects of Avanafil on Semen Parameters Erectile Dysfunction | Phase 4 | 2012-12-01 |
| Completed | Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction Erectile Dysfunction | Phase 4 | 2012-09-01 |
| Completed | VI-1121 for the Treatment Alzheimer's Disease Alzheimer's Disease | Phase 2 | 2011-08-01 |
| Completed | Study the Effect of Avanafil on the Pharmacodynamics and Pharmacokinetics of Warfarin in Healthy Male Subjects Erectile Dysfunction | Phase 1 | 2010-04-01 |
| Completed | Drug Interaction Study of Avanafil and Enalapril or Amlodipine Erectile Dysfunction | Phase 1 | 2010-04-01 |
| Completed | Compare the Pharmacokinetics of Omeprazole, Rosiglitazone, and Desipramine When Administered With Avanafil in Erectile Dysfunction | Phase 1 | 2010-04-01 |
| Completed | Assess the Effect of Food on Avanafil Pharmacokinetic (PK), to Compare 2 Oral Formulations of Avanafil,and Inv Healthy | Phase 1 | 2010-04-01 |
| Completed | Hemodynamic Study of Avanafil and Two α-Adrenergic Blockers,Doxazosin and Tamsulosin Erectile Dysfunction | Phase 1 | 2010-02-01 |
| Terminated | A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray a Hypoactive Sexual Desire Disorder | Phase 1 | 2010-02-01 |
| Completed | To Assess the Safety of Avanafil in Healthy and Hepatically Impaired Male Subjects. Erectile Dysfunction | Phase 1 | 2010-01-01 |
| Completed | To Compare the Pharmacokinetics of Avanafil in Subjects With Mild and Moderate Renal Impairment to Subjects Wi Renal | Phase 1 | 2010-01-01 |
| Completed | A Phase I Crossover Study of the Hemodynamic Interactions of Avanafil & Alcohol in Healthy Male Subjects. Erectile Dysfunction | Phase 1 | 2010-01-01 |
| Completed | A Pharmacokinetic Study of Avanfil in Healthy Young Male Subjects Avanfil ADME, Semen Exposure, Sperm Function | Phase 1 | 2009-05-01 |
| Completed | Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy Erectile Dysfunction | Phase 3 | 2009-04-01 |
| Completed | Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction Erectile Dysfunction | Phase 3 | 2009-03-01 |
| Completed | A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects. Obesity | Phase 1 | 2009-02-01 |
| Completed | A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers Torsades de Pointes | Phase 1 | 2009-02-01 |
| Completed | Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female Subjects Healthy | Phase 1 | 2009-01-01 |
| Completed | A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-R Obesity | Phase 3 | 2008-12-01 |
| Completed | Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D) Erectile Dysfunction | Phase 3 | 2008-12-01 |
| Completed | A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects. Overweight, Obesity | Phase 2 | 2008-12-01 |
| Completed | Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED Erectile Dysfunction | Phase 3 | 2008-11-01 |
| Completed | A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment Renal Impairment | Phase 1 | 2008-10-01 |
| Completed | A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic Impairment Hepatic Impairment | Phase 1 | 2008-10-01 |
| Completed | To Evaluate The Effect Of Ketoconazole, Ritonavir and Erythromycin on the Safety and Pharmacokinetics of Avana Erectile Dysfunction | Phase 1 | 2008-10-01 |
| Completed | A Thorough EKG Safety Study of TA-1790 (Avanafil) Erectile Dysfunction | Phase 1 | 2008-10-01 |
| Terminated | Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic Adults Diabetes | Phase 2 | 2008-08-01 |
| Completed | A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults Sleep Apnea | Phase 1 / Phase 2 | 2008-08-01 |
| Completed | A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic Adults Diabetes | Phase 2 | 2008-01-01 |
| Completed | A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity | Phase 3 | 2007-12-01 |
| Completed | Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Mo Obesity, Type 2 Diabetes | Phase 3 | 2007-11-01 |
| Completed | Study of VI-0521 Compared to Placebo in Treatment of Obesity in Adults Obesity | Phase 3 | 2007-11-01 |
| Completed | Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults Obesity | Phase 1 | 2007-07-01 |
| Completed | Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics Type 2 Diabetes Mellitus | Phase 2 | 2007-06-01 |
| Completed | Topical Alprostadil for Female Sexual Arousal Disorder Sexual Dysfunction, Physiological | Phase 2 | 2004-09-01 |
| Completed | Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA Erectile Dysfunction | Phase 1 | 2004-03-01 |